Wells Fargo downgraded Affimed (AFMD) to Equal Weight from Overweight with a price target of 10c, down from $11, following the announcement that the company is opening insolvency proceedings given that the company’s liquidity condition raises substantial doubt about its ability to continue as a going concern. Though there is value in acimtamig, the small market opportunity likely has limited the company’s ability to access capital, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFMD:
